Anti-Helicobacter pylori activity of Plumbago zeylanica L by Wang,  Y.C. & Huang,  T.L.
www.fems-microbiology.org
FEMS Immunology and Medical Microbiology 43 (2005) 407–412Anti-Helicobacter pylori activity of Plumbago zeylanica L.
Yuan-Chuen Wang *, Tung-Liang Huang
Department of Food Science, National Chung-Hsing University, 250 Kuokuang Road, Taichung 40227, Taiwan, 402, ROC
Received 20 August 2004; received in revised form 15 October 2004; accepted 18 October 2004
First published online 25 November 2004Abstract
It has been shown that the presence of infection by Helicobacter pylori is strongly associated with gastric cancer and peptic ulcer-
ation. In western medicine, a 3-fold therapeutic regimen, emphasizing the use of antibiotics, is typically used to suppress H. pylori
activity. However, antibiotic drug resistance frequently develops as a consequence of such treatment. In our previous study, 50 Tai-
wanese folk medicinal plants were screened for their anti-H. pylori activities. The results revealed that Plumbago zeylanica L. had the
highest inhibitory eﬀects against H. pylori. In this study, therefore, we have focused on establishing the anti-H. pylori activities of P.
zeylanica L. Water and the organic solvents ethanol, ethyl acetate and acetone were used for P. zeylanica L. extraction, obtaining
yields of 1.66–6.84% (w/w). Excluding the water extract, higher anti-H. pylori activity was demonstrated for all the extracts, both
using the agar diﬀusion and dilution methods. The ethyl acetate extract exhibited the lowest minimum inhibitory concentrations
against ﬁve H. pylori strains, of which ranged from 0.32 to 1.28 mg ml1, followed, in ascending order, by the acetone, ethanol
and water analogs. Bactericidal activity was determined for P. zeylanica L. extracts, with the lowest minimum bactericidal concen-
trations (5.12–20.48 mg ml1) demonstrated for the ethyl acetate, followed, in ascending order, by the acetone and ethanol analogs.
Bactericidal activity appeared to be in a dose-dependent manner. Through a broad pH range (2–7), bactericidal activity was not
aﬀected when extract concentrations were greater than or equal to the minimum bactericidal concentration. High stability was dem-
onstrated for the ethyl acetate P. zeylanica L. extract within pH range of 1–7, exhibiting all pH treatments bactericidal activity.
 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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Infection with Helicobacter pylori is strongly associ-
ated with duodenal and gastric ulcers [1]. Many of the
epidemiological studies have indicated that high rates
of H. pylori infection may be related to the preva-
lence of gastric cancer and adenocarcinoma [2]. Various
pharmacological regimens have been studied for the
treatment of H. pylori infection. Antibiotics [3,4], pro-
ton-pump inhibitors [5,6], H2-blockers [7,8] and bismuth
salts [9] are the suggested standard treatment modalities,0928-8244/$22.00  2004 Federation of European Microbiological Societies
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E-mail address: ycwang@dragon.nchu.edu.tw (Y.-C. Wang).typically combined in dual, triple and quadruple-therapy
regimens to eradicate H. pylori [10,3]. Problems encoun-
tered when administering these eradication regimens, in-
clude cost [10], the eﬃcacy of antibiotics relative to pH,
for instance, amoxicillin is most active at a neutral pH,
and tetracycline has greater activity at a low pH [10],
and resistance to the antibiotics [11]. Further, more than
15% of the patients undergoing such drug regimens
experience therapeutic failure [10].
Plumbago zeylanicaL. is a semi-climbing subshrub that
grows throughout Asia and Africa. This plant is distrib-
uted in thickets or grassland at low elevations in Taiwan
[12]. The whole plant and its roots have been used as folk
medicine in the treatment of rheumatic pain, dysmenor-
rhea, carbuncles, contusion of the extremities, ulcers and. Published by Elsevier B.V. All rights reserved.
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dianmedicine,P. zeylanicaL. has been assignedmedicinal
properties and is used in formulations of a number of
ayurvedic compounds [14]. In southwestern Nigeria, P.
zeylanica L. is used in folk medicine to treat parasitic dis-
eases, scabies and ulcers [15]. Pharmacological studies car-
riedout by severalworkers have indicated thatP. zeylanica
L. extract has antiplasmodial [16], antimicrobial [13,17,
18], antihyperglycemic [19], insecticidal [20] and antialler-
gic [21] properties. It also stimulates the central nervous
system [22] and is cytotoxic for tumor cell activities [23].
In our previous study, 50 Taiwanese folk medicinal
plants were screened for their anti-H. pylori activities.
The results revealed that P. zeylanica L. had the stron-
gest inhibitory eﬀect against H. pylori. In this study,
therefore, we have focused on the anti-H. pylori activi-
ties of P. zeylanica L.. Anti-H. pylori spectra were stud-
ied using the agar diﬀusion method and minimum
inhibitory concentration (MIC) and minimum bacterici-
dal concentration (MBC) established using the agar
dilution method; time-kill assay for the ethyl acetate ex-
tract on the bactericidal activity was determined and the
eﬀects of pH and pH stability on the bactericidal activ-
ities of P. zeylanica L. extract were also examined.2. Materials and methods
2.1. Herbal plant and preparation of herbal extracts
Samples of P. zeylanica L. were collected and identi-
ﬁed by Technician N. Y. Chiu from the Institute of Chi-
nese Pharmaceutical Science China Medical College.
Voucher specimens (No. 250481) were deposited at the
Institute of Ecology and Evolutionary Biology, College
of Life Sciences, National Taiwan University.
The dried, mixed, rhizome and radix of P. zeylanica L.
were used for the preparation of herbal extracts in water,
ethanol, acetone or ethyl acetate as extraction solvents.
Two-hundred milliliters of extraction solvent were added
to 30 g of ground (passed through a 60mesh screen) herbal
plant followed by stirring 1 h at room temperature. Subse-
quently, themixturewas centrifugedat 9000 rpmfor15min
at 4 C and the residue was extracted twice with 2 · 200 ml
of extraction solvent. The supernatants were mixed and
concentrated to dryness in a rotary vacuum evaporator at
less than 40 C (below 50 C in case of water extracts),
and the concentrate was then weighed. Extraction yield
(%, w/w) was calculated as a ratio of the weight of the con-
centrate to the weight of the P. zeylanica L. powder.2.2. Bacterial strains and culturing
Helicobacter pylori BCRC 15415, BCRC 17021,
BCRC 17023, BCRC 17026 and BCRC 17027 were ob-tained from the Bioresources Collection and Research
Center (BCRC), Hsinchu, Taiwan, ROC.
The ﬁve strains of H. pylori were cultured in 5-ml
tryptic soy broth (TSB, Difco, USA; each liter contain-
ing: a pancreatic digest of casein [17 g], an enzymatic di-
gest of soybean meal [3 g], dextrose [2.5 g], sodium
chloride [5 g], and dipotassium phosphate [2.5 g, pH
7.3]), with Columbia agar (bioMe´rieux, France; each li-
ter containing: bio-polyone [10 g], bio-lysat [10 g], bio-
myotone [3 g], corn starch [1 g], sodium chloride [5 g]
and agar [13.5 g, pH 7.3]) slant containing 5% (v/v) deﬁ-
brinated sheep blood formed at the bottom of the test
tube. The broth was then incubated in a microaerophilic
jar system (BBL), presenting a gas composition of 5%
O2 and 10% CO2 in air (an OXOID BR 056A gas-gen-
erating kit was used for this purpose) at 37 C for 72 h.
The cell suspension was then diluted with 0.1% peptone
to produce a cell concentration of 0.5–1.0 · 106 cfu ml1
for antimicrobial testing.
2.3. Inhibitory-zone testing
The water, ethanol, acetone and ethyl acetate extracts
of P. zeylanica L. were used for inhibitory-zone testing.
The anti-H. pylori inhibitory-zone testing consisted of
four extracts of P. zeylanica L. against ﬁve strains of
H. pylori, according to the method of Johnson et al.,
(1995) [24]. A volume of 0.1-ml of each tested H. pylori
suspension (0.5–1.0 · 106 cfu ml1) was spread onto a
Columbia agar plate containing 5% (v/v) deﬁbrinated
sheep blood. Wells of 7 mm in diameter were punched
on the plates and 30 ll of the P. zeylanica L. extract
[0.2 g ml1; dimethyl sulfoxide (DMSO) as solvent]
was individually incorporated into the wells. DMSO
was used as control. The plates were diﬀused at 4 C
for 2 h and subsequently incubated in a microaerophilic
jar system (5% O2 and 10% CO2) at 37 C for 72 h. The
clear zone around each well was observed and its diam-
eter was examined.
2.4. Minimum inhibitory concentration and minimum
bactericidal concentration testing
The MICs for the water, ethanol, acetone and ethyl
acetate extracts of P. zeylanica L. were established
against the ﬁve strains of H. pylori, using a broth-dilu-
tion method [25]. Each of the P. zeylanica L. extracts
was dissolved in DMSO and 2-fold diluted in Colum-
bia agar containing 5% (v/v) deﬁbrinated sheep blood.
DMSO was used as control. A volume of 0.1-ml of cell
suspension (0.5–1.0 · 106 cfu ml1) was spread onto
Columbia agar plates containing 5% (v/v) deﬁbrinated
sheep blood. Colonies that had formed on the plates
were enumerated following incubation in a microaero-
philic jar system (5% O2 and 10% CO2 in air) at 37 C
for 72 h. The MICs for the P. zeylanica L. extracts
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ﬁned as the lowest concentration of the test sample
at which no colony of the test bacteria on the plate
was formed.
The MBCs for the ethanol, acetone and ethyl ace-
tate extracts of P. zeylanica L. were determined. For
MBC testing, like as the MIC testing, a broth-dilution
method [25] was used. Each of the P. zeylanica L. ex-
tracts was dissolved in DMSO and 2-fold diluted in
Columbia agar containing 5% (v/v) deﬁbrinated sheep
blood or TSB, and was then individually added to test
tubes, with Columbia agar slants formed at the bottom
of the test tubes and the TSB layer to be covered on
the slants, both the slant and broth contained the same
concentrations of the extract. DMSO was used as con-
trol. H. pylori suspensions were added to the TSB layer
to produce 0.5–1.0 · 106 cfu ml1 of the initial bacterial
count. Following incubation in a microaerophilic jar
system (5% O2 and 10% CO2 in air) at 37 C for 72
h. A volume of 0.1-ml of each suspension was spread
onto Columbia agar plates containing 5% (v/v) deﬁ-
brinated sheep blood, but lacking the ethyl acetate P.
zeylanica L. extract. After incubation in a microaero-
philic jar system (5% O2 and 10% CO2 in air) at 37
C for 72 h, the colonies formed were subsequently
enumerated. The MBC was deﬁned as the lowest con-
centrations of the P. zeylanica L. extract giving com-
plete inhibition of colony formation of the test
bacteria at the latter cultivation.
2.5. Time-kill assay
The time-kill assay for the ethyl acetate extract of P.
zeylanica L. was determined. Forty milliliters of
Columbia agar containing 5% (v/v) deﬁbrinated sheep
blood at ﬁnal concentrations of 0–20.48 mg ml1 (w/
v) of the ethyl acetate P. zeylanica L. extract were
added to a 250-ml ﬂask to create a plate at the bottom
of the ﬂask. Fifty milliliters of TSB containing the
same concentrations of the ethyl acetate P. zeylanica
L. extract were poured onto the plate. No extract
was added to the control samples. A volume of 0.1-
ml of H. pylori BCRC 17023 cell suspension was added
to the TSB layer to produce 1.0 · 108 cfu ml1 of the
initial bacterial count. The broth was incubated in a
microaerophilic jar system (5% O2 and 10% CO2 in
air) at 37 C for 72 h. At various intervals during the
incubation period, the broths were taken and diluted
by 10-fold dilutions in 0.1% peptone solution. A vol-
ume of 0.1-ml of each suspension was spread onto
Columbia agar plates containing 5% (v/v) deﬁbrinated
sheep blood, but lacking the ethyl acetate P. zeylanica
L. extract. Upon incubation in a microaerophilic jar
system (5% O2 and 10% CO2 in air) at 37 C for 72
h, the colonies that had formed on the Columbia agar
plates were enumerated.2.6. Eﬀect of the pH on bactericidal activity
The ethyl acetate extract of P. zeylanica L. was used
to examine the eﬀect of pH on bactericidal activity. Five
milliliters of the Columbia agar containing 5% (v/v) deﬁ-
brinated sheep blood (adjusted to pH 2–7 with 3 N HCl)
at ﬁnal concentrations of 0–20.48 mg ml1 of the ethyl
acetate P. zeylanica L. extract were added to the test
tubes to create slants at the bottom. Four milliliters of
TSB (adjusted to pH 2–7 with 3 N HCl) containing
the same concentration of the ethyl acetate P. zeylanica
L. extract were poured onto the slants. Untreated slant
broth was used as control. A volume of 0.1-ml of the
H. pylori BCRC 17023 cell suspension was added to
the TSB to produce 1.0 · 108 cfu ml1 of the initial bac-
terial count. The broths were incubated in a microaero-
philic jar system (5% O2 and 10% CO2 in air) at 37 C
for 24 h. Each of the broths was sampled and diluted
by 10-fold dilutions in 0.1% peptone solution. A volume
of 0.1-ml from each of the diluted samples was spread
onto Columbia agar plates containing 5% (v/v) deﬁbrin-
ated sheep blood, but lacking the ethyl acetate P. zeyla-
nica L. extract. After incubation in a microaerophilic jar
system (5% O2 and 10% CO2 in air) at 37 C for 72 h, the
colonies formed on the Columbia agar plates were
enumerated.
2.7. Ethyl acetate P. zeylanica L. extracts – pH stability
The pH stability of the ethyl acetate P. zeylanica L.
extract on bactericidal activity was tested. The pH-trea-
ted extracts were prepared using the Clark and Lubs
(pH 1–2) and McIlvaine buﬀers (pH 3–7) [8% (w/v)]
[26]; being all the extracts stored at room temperature
for 2 h.
Five milliliters of Columbia agar, containing 5%
(v/v) of deﬁbrinated sheep blood at 10.24 mg ml1
of the pH-treated ethyl acetate P. zeylanica L. extracts
were added to each test tube to create slants at the
bottom. Five milliliters of TSB containing the same
concentrations of the pH-treated ethyl acetate extract
as the slant were poured onto the slants. Untreated
slant broth was used as control. A volume of 0.1-ml
of H. pylori BCRC 17023 cell suspension was added
to the TSB to produce 1.0 · 108 cfu ml1 of the initial
bacterial count. Broths were incubated in a microaer-
ophilic jar system (5%O2 and 10%CO2 in air) at 37 C for
24 h. Each broth was sampled and diluted by 10-fold
dilutions in 0.1% peptone solution. A volume of
0.1-ml of each diluted sample was then spread onto
Columbia agar plates containing 5% (v/v) deﬁbrinated
sheep blood, but lacking the ethyl acetate P. zeylanica
L. extract. After incubation at 37 C for 72 h in a micro-
aerophilic jar system (5% O2 and 10% CO2 in air), the
colonies grown on the Columbia agar plates were
enumerated.
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3.1. Extraction yields
P. zeylanica L. extraction was accomplished using
solvents of diﬀerent polarities (water, ethanol, acetone
and ethyl acetate: polarity indexes (P) of 10.2, 5.2, 5.1
and 4.4, respectively). The greatest yields were obtained
using water and ethanol (6.84% and 6.28% (w/w),
respectively), followed, in descending order, by acetone
and ethyl acetate (2.03% and 1.66%, respectively).
3.2. Anti-H. pylori spectra of P. zeylanica L. extract
The agar diﬀusion method [24] was used to study the
anti-H. pylori spectra of the four P. zeylanica L. extracts.
The results are presented in Table 1. Among the four ex-
tracts, ethanol, acetone and ethyl acetate extracts exhib-
ited relatively high anti-H. pylori activities, forming
large-diameter clear zones on the plate and for all the test
strains. Less anti-H. pylori activity was observed in case
of the water extract, with inhibitory zones very unclear.
Ethanol, acetone and ethyl acetate are classiﬁed as
moderate polarity solvents. Thus, we assumed that the
P. zeylanica L. extract presenting a greater anti-H. pylori
activity would also have a greater content of com-
pounds with moderate polarity. A variety of compounds
have been isolated from P. zeylanica L. including: naph-
thoquinones, such as plumbagin [13,27], droserone,
isoshinanolone and the new variant, 1,2(3)-tetrahydro-
3,3 0-biplumbagin [27]; metroterpenes, such as bakuchiol
and 12-hydroxyisobakuchiol [28]; C-glucosylﬂavonoids;
and saponaretin [28]. Given that all of these have moder-
ate polarity, it seems reasonable to suggest that contrib-
utors to the anti-H. pylori activities of P. zeylanica L. are
composed by one or more of the above compounds.
3.3. Minimum inhibitory concentration and minimum
bactericidal concentration testing
Inhibitory-zone testing is the primary method for
evaluation of the susceptibility of the test samplesTable 1
Anti-H. pylori spectra of the four solvent extractsa
H. pylori strain Inhibitory zone
Water Ethanol Acetone Ethyl acetate
BCRC 15415 +++(H) ++++ ++++ ++++
BCRC 17021 ++b (H)c +++ +++ +++
BCRC 17023 + ++++ +++ ++++
BCRC 17026 +(H) +++(H) +++(H) ++++(H)
BCRC 17027 +++(H) ++++ ++++ ++++
a Four extracts with concentrations of 0.2 g ml1 and 30 ll were
incorporated into each well.
b ++++, >20 mm (dia); +++, 16–20 mm; ++, 11–15 mm; +, 8–10
mm; , 67 mm.
c hazy zone.against speciﬁc microorganisms. Given the relatively
low sensitivity of this method, MIC testing is mainly
used as complementary method to evaluate the antimi-
crobial activity of the test sample. The MIC results for
the water, ethanol, acetone and ethyl acetate of P. zeyla-
nica L. extracts are shown in Table 2. Among the four
extracts, the ethyl acetate variant had the lowest MICs
against the ﬁve H. pylori strains (0.32–1.28 mg ml1),
which was followed, in ascending order, by the acetone
and ethanol extracts (0.32–10.24 and 0.64–10.24 mg
ml1, respectively). In fact, there were minimal diﬀer-
ences between the acetone and ethanol extracts. The
water extract showed more than 10.24 mg ml1 of MICs
against four H. pylori strains, having the higher MIC in
comparison to the values registered in the other three ex-
tracts. Both agar diﬀusion and dilution methods used in
the evaluation of the P. zeylanica L. extract for H. pylori
susceptibility, gave similar results as demonstrated in
Tables 1 and 2. This indicated that, among the four
tested solvents, the ethyl acetate was the most eﬃcient
solvent for the P. zeylanica L. compounds in terms of
anti-H. pylori activity.
Cellini et al., (1996) reported that the phosphate ex-
tract of garlic possesses anti-H. pylori activity, with
MICs for the extract against 19 strains of H. pylori rang-
ing from 2 to 5 mg ml1 [29], supporting our ﬁndings in
this study. In contrast, the anti-H. pylori activity of the
methanol extract of Myroxylon peruiferum, a medicinal
plant of Brazil, with 62.5 mg ml1 of MIC was lower
than the equivalent in our study [30]. In our previous
study [31], antagonistic activity against ten H. pylori
strains was demonstrated for the ethyl acetate extract
of Elephantopus scaber Linn. (MIC range 2.56–10.24
mg ml1), a Taiwanese folk medicinal plant.
To determine whether a test compound had bacterici-
dal activity, microorganisms were initially cultivated in
the presence of the test compound contained in the
broth and subsequently, sampled, inoculated and re-cul-
tivated in the absence of the test compound. If no colony
formation was observed at that point, the test com-
pound had bactericidal activity [32]. Thus, minimum
bactericidal concentration was deﬁned as the lowest con-
centration at which the test compound could give com-
plete inhibition of growth. MBCs for the P. zeylanica L.Table 2
Minimum inhibitory concentrations of the four P. zeylanica L. extracts
against H. pylori.
H. pylori strain MIC (mg ml1)
Water Ethanol Acetone Ethyl acetate
BCRC 15415 >10.24 0.64 0.64 0.64
BCRC 17021 1.28 0.64 0.32 0.32
BCRC 17023 >10.24 2.56 1.28 0.64
BCRC 17026 >10.24 10.24 10.24 1.28
BCRC 17027 >10.24 2.56 2.56 1.28
Table 3
Minimum bactericidal concentrations of three extracts of P. zeylanica
L. against H. pylori
H. pylori strain MBC (mg ml1)
Ethanol Acetone Ethyl acetate
BCRC 15415 20.48 20.48 20.48
BCRC 17021 10.24 5.12 5.12
BCRC 17023 40.96 20.48 10.24
BCRC 17026 81.92 81.92 20.48
BCRC 17027 40.96 20.48 20.48
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acetone and ethyl acetate extracts bactericidal activity.
The lowest MBCs against the ﬁve strains of H. pylori
(5.12–20.48 mg ml1) was shown for the ethyl acetate
extract and followed by the acetone and ethanol analogs
(MBC 5.12–81.92 and 10.24–81.92 mg ml1, respec-
tively). Hence, MBC and MIC results appeared to be
consistent (Table 2).
3.4. Time-kill assay
Ethyl acetate extracts of P. zeylanica L. were added
to theH. pylori BCRC 17023 broth to produce ﬁnal con-
centrations of 0–20.48 mg ml1. At diﬀerent time inter-
vals during cultivation, the broth was sampled, diluted
and the total colony counts on the plates were enumer-
ated in order to determine the relationship between the
concentration of ethyl acetate extract, treatment time
and bactericidal activity (Fig. 1). Only anti-H. pylori
activity and not bactericidal activity was determined,
were concentration of the ethyl acetate extract in the
broth (5.12 mg ml1) was lower than the MBC (10.24
mg ml1 against H. pylori BCRC 17023), it was solely
four logs of bacterial counts decreased. Bactericidal
activity was observed where concentration of the ethylTreatment time (h)
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Fig. 1. Time-kill assay for the ethyl acetate P. zeylanica L. extracts
against H. pylori BCRC 17023, (--) control; (-,-) 5.12 mg ml1; (-h-)
10.24 mg ml1; and, ð}Þ 20.48 mg ml1.acetate extract was equal to the MBC value, being nec-
essary 8 h to eradicate the H. pylori BCRC 17023. When
concentration of the ethyl acetate extract (20.48 mg
ml1) in the broth was greater than the MBC, the time
needed to kill the H. pylori BCRC 17023 was reduced
to 4 h. In summary, our results indicated that the bacte-
ricidal action of the ethyl acetate extract of P. zeylanica
L. appeared to be dose dependent (Fig. 1).
3.5. Eﬀect of pH on bactericidal activity
For the treatment of H. pylori infections, antibiotics
are typically used in therapy regimen. However, the eﬃ-
cacy of the antibiotics appears to be pH dependent. For
example, amoxicillin is most active at neutral pH and
tetracycline presents greater activity at low pH [10]. In
this study, therefore, the eﬀect of the pH on the bacteri-
cidal activity given by the ethyl acetate P. zeylanica L.
extract was investigated. The results shown in Fig. 2,
where concentration of the ethyl acetate extracts in the
broth was above the MBC value, bactericidal activity
was demonstrated and appeared to be independent of
the pH (unaltered at pH 2–7). However, when concen-
tration of the ethyl acetate extract was lower than the
MBC, it was observed a dose-dependent anti-H. pylori
action, where the total bacterial counts in the broth in-
creased when the pH was also raised. Similar results
were also obtained in the anti-H. pylori activity of Ele-
phantopus scaber Linn. [31] when the concentration of
the extract was greater than its MBC value, i.e., present-
ing a bactericidal action not inﬂuenced at pH 2–7. Fig. 2
showed that in the control samples, H. pylori did not
survive at pH 2 and 3 and it only started to grow when
the pH was above 3.pH
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Fig. 2. pH eﬀect on the ethyl acetate P. zeylanica L. extracts on the
bactericidal activity against H. pylori BCRC 17023, (--) control; (-,-)
5.12 mg ml1; (-h-) 10.24 mg ml1; ð}Þ 20.48 mg ml1.
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When administrated orally, the drugs commonly will
remain in the stomach for 1–2 h, where the gastric-juice
pH is typically 1–2, thus the activity of drugs being inﬂu-
enced by the acidic pH. In this study, the stability of the
ethyl acetate P. zeylanica L. extract was examined rela-
tive to its pH, i.e., the extract was resuspended in diﬀerent
buﬀer solutions (pH 1–7 for 2 h) to determine the eﬀect on
the bactericidal activity. The results showed that the ethyl
acetate P. zeylanica L. extracts had a high stability in a
wide range of pH (1–7), exhibiting all pH treatments bac-
tericidal activity at 10.24 mg ml1, and therefore, no col-
ony formation detected on the plate (data not shown).
In summary, the bactericidal activity of the ethyl ace-
tate P. zeylanica L. extract appeared either to be inde-
pendent of pH ﬂuctuations or to be very stable (Fig.
2), which oﬀers signiﬁcant advantages, i.e., greater con-
venience and reduced cost for the treatment of H. pylori
infections in comparison to proton-pump inhibitors or
H2-blockers treatments.References
[1] Clyne, M. and Drumm, B. (1993) Adherence of Helicobater pylori
to primary human gastrointestinal cells. Infect. Immun. 61, 4051–
4057.
[2] Forman, D., Newekk, D.G., Fullerton, F., Yarnell, J.W.G.,
Stacey, A.R., Wald, N. and Sitas, F. (1991) Association between
infection with Helicobacter pylori and risk of gastric cancer:
evidence from a prospective investigation. Br. Med. J. 302, 1302–
1305.
[3] Fera, M.T., Carbone, M., Pallio, S., Tortora, A., Blandino, G.
and Carbone, M. (2001) Antimicrobial activity and postantibiotic
eﬀect of ﬂurithromycin against Helicobacter pylori strains. Int. J.
Antimicrob. Agents 17, 151–154.
[4] Boyanova, L. (1999) Comparative evaluation of two methods for
testing metronidazole susceptibility of Helicobacter pylori in
routine practice. Diagn. Microb. Infect Dis. 35, 33–36.
[5] Park, J.B., Imamur, L.L. and Kobashi, K. (1996) Kinetic studies
of Helicobacter pylori urease inhibition by a novel proton pump
inhibitor, rabeprazole. Biol. Parm. Bull. 19, 182–187.
[6] Tuschiya, M., Imamura, L., Park, J.B. and Kobashi, K. (1995)
Helicobacter pylori urease by rabeprazole, a proton pump
inhibitor. Biol. Pharm. Bull. 18, 1053–1056.
[7] Susan, M. and Mou, M.D. (1998) The relationship between
Helicobacter pylori infection and peptic ulcer disease. Prim. Care
Update Ob/Gyns 5, 229–232.
[8] Sorba, G., Bertinaria, M., Stilo, A.D., Gasco, A., Scaltrito, M.M.,
Brenciaglia, M.I. and Dubini, F. (2001) Anti-Helicobacter pylori
agents endowed with H2-antagonist properties. Bioorg. Med.
Chem. Lett. 11, 403–406.
[9] Midolo, P.D., Norton, A., Itzstein, M.V. and Lambert, J.R.
(1997) Novel bismuth compounds have in vitro activity against
Helicobacter pylori. FEMS Microb. Lett. 157, 229–232.
[10] Worrel, J.A. and Stoner, S.C. (1998) Eradication of Helicobacter
pylori. Med. Update Psychiatrsits 4, 99–104.
[11] Ferrero, M., Ducons, J.A., Sicilia, B., Santolaria, S., Sierra, E.
and Gomollon, F. (2000) Factors aﬀecting the variation in
antibiotic resistance of Helicobacter pylori over a 3-year period.
Int. Antimicrob. Agents 16, 245–248.[12] Li, H.L. (1998) Plumbaginaceae. In: Flora of Taiwan (Editorial
Committee of the Flora of Taiwan, Eds.), Vol. IV, Second ed., pp.
79–82.
[13] Chiu, N.Y. and Chang, K.H. (2003) Fifth ed., The Illustrated
Medicinal Plants of Taiwan, Vol. 2. SMC Publishing Inc., Taipei,
pp. 152–153.
[14] Kirtikar, K.R. and Basu, B.D. (1993) Indian Medicinal Plants,
Vol. 2. Shiva Publishers, Dehradun, India, pp. 1466–1468.
[15] Daiziel, J.M. (1959) The useful plants of west tropical Africa. In:
London: The crown agents for the colonies, p. 424.
[16] Simonsen, H.T., Nordskjold, J.B., Smitt, U.W., Nyman, U.,
Palpu, P., Joshi, P. and Varughese, G. (2001) In vitro screening of
Indian medicinal plants for antiplasmodial activity. J. Ethno-
pharmacol. 74, 195–204.
[17] Durga, R., Sridhar, P. and Polasa, H. (1990) Eﬀect of plumbagin
on antibiotic resistance in bacteria. Indian J. Med. Res. [A] 91,
18–20.
[18] Atkinson, N. (1956) Antibacterial substances from ﬂowering
plants. 3. Antibacterial activity of dried Australlian plants by a
rapid direct plate test. Austral. J. Exp. Biol. 34, 17–26.
[19] Olagunju, J.A., Jobi, A.A. and Oyedapo, O.O. (1999) An
investigation into the biochemical basis of the observed hyper-
glycaemia in rats treated with ethanol root extract of Plumbago
zeylanica. Phytotherapy Res. 13, 346–348.
[20] Kubo, I., Uchida, M. and Klocke, J.A. (1983) An insect ecdysis
inhibitor from the Africa medicianl plant, Plumbago capensis.
Agric. Biol. Chem. 47, 911–913.
[21] Dai, Y., Hou, L.F., Chan, Y.P., Cheng, L. and Bur, P.P.H. (2004)
Inhibition of immediate allergic reactions by ethanol extract from
Plumbago zeylanica stems. Biol. Pharm. Bull. 27, 429–432.
[22] Bopaiah, C.P. and Pradhan, N. (2001) Central nervous system
stimulatory action from the root extract of Plumbago zeylanica in
rats. Phytotherapy Res. 15, 153–156.
[23] Lin, L.C., Yang, L.L. and Chou, C.J. (2003) Cytotoxic naphtho-
quinones and plumbagic acid glucosides from Plumbagp zeyla-
nica. Phytochemistry 62, 619–622.
[24] Johnson, T.R. and Christine, L.C. (1995) Laboratory experiments
in microbiology. The Benjamin/Cummings Pub. Co. Inc., New
York, pp. 177–179.
[25] Davidson, P.M. and Parish, M.E. (1989) Methods for testing the
eﬃcacy of food antimicrobials. Food Technol. 43, 148–155.
[26] Dawson, R.M.C., Elliott, D.C., Eliiott, W.H. and Jones, K.M.
(1978) Data for biochemical research. Clarendon Press, Oxford,
pp. 483–485.
[27] Gunaherath, G.M.K.B., Gunatilaka, A.A.l., Sultanbawa, M.U.S.
and Balasubramaniam, S. (1983) 1,2(3)-Tetrahydro-3,30-biplum-
bagin: a naphthalenone and other constituents from Plumbago
zeylanica. Phytochemistry 22, 1245–1247.
[28] Lin, L.C. and Chou, C.J. (2003) Metroterpenes and C-glucosylﬂ-
avonoids from the aerial parts of Plumbago zeylanica. Chin.
Pharm. J. 55, 77–81.
[29] Cellini, L., Campli, E.D., Masulli, M., Bartolomeo, S.D. and
Allocati, N. (1996) Inhibition of Helicobacter pylori by garlic
extract (Allium sativum). FEMS Immunol. Med. Microb. 13, 277–
279.
[30] Ohsaki, A., Takashima, J., Chiba, N. and Kawamura, M. (1999)
Microanalysis of a selective potent anti-Helicobacter pylori com-
pound in a Brazillian medicinal plant, Myroxylon peruiferum and
the activity of analogues. Bioorg. Med. Chem. Lett. 9, 1109–1112.
[31] Wang, Y.C. and Xu, B.K. (2003) Studies on the anti-Helicobacter
pylori activity of ethyl acetate of Elephantopus scaber Linn.
Taiwan. J. Agric. Chem. Food Sci. 41, 228–235.
[32] Coudron, P.E. and Stratton, C.W. (1998) The bactericidal activity
of clarithromycin verus ampicillin alone and in combination with
omeprazole and/or bismuth against clarithromycin-suspceptible
and clarithromycin-resistant strains of Helicobacter pylori. Diagn.
Microb. Infect Dis. 31, 39–44.
